ALZN · Alzamend Neuro, Inc. · Investor Relations
$1.21
-0.05 (-3.60%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors create substantial doubt about our ability to continue as a going concern for at least one year after the date that our condensed financial statements are issued.”View the 10-Q filed Sep 10, 2026
Market Cap
$6.49M
Shares
4.83M
Volume · Oct 22
12.88K
Avg daily vol (3M)
81K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-18 00:00 UTC | Neuroscience 2026, the annual meeting of the Society for Neuroscience ("SfN") | Shareholder meeting |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-10-01 | International Society for Magnetic Resonance in Medicine ("ISMRM") Workshop on Beyond Protons: Challenges and Advances in X-Nuclei MR | Event |
| 2026-04-17 | 2026 Annual Meeting of Stockholders | Shareholder meeting |